Polianta LTD Fibrogen Inc Transaction History

Polianta LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 06, 2021	SELL	$18.57 - $35.68 $640,665 - $1.23 Million	-34,500 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$31.0 - $55.72 $99,200 - $178,304	3,200 Added 10.22%	34,500 $1.2 Million
Q4 2020 Jan 13, 2021	BUY	$37.09 - $48.97 $144,651 - $190,983	3,900 Added 14.23%	31,300 $1.16 Million
Q3 2020 Oct 07, 2020	BUY	$40.47 - $45.5 $1.11 Million - $1.25 Million	27,400 New	27,400 $1.13 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $54.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.